BUSINESS

Quest Diagnostics Reports Strong Q1, Raises Guidance

▪

Read, Watch or Listen

Media Bias Meter

Sources: 3

Center 100%

Sources: 3

SECAUCUS, N.J. — Quest Diagnostics reported first-quarter 2026 results on April 21, 2026, announcing net income of about $251–$252 million, GAAP EPS of $2.24 and adjusted EPS of $2.50 on revenue near $2.9 billion. The company also updated full-year adjusted diluted EPS guidance to $10.63–$10.83 and net revenue guidance to $11.78–$11.90 billion. The results topped Zacks consensus estimates for both earnings and revenue on Tuesday, and management cited roughly 9% organic revenue growth in the quarter when raising guidance. In pre-market trading this week, Quest shares were reported up about 2.39 percent, and analysts and investors will monitor second-quarter trends and execution against the revised 2026 outlook.

Prepared by Christopher Adams and reviewed by editorial team.

Timeline of Events

March 31, 2026: End of Quest Diagnostics' first-quarter reporting period.
April 21, 2026: Quest issued Q1 financial results and updated full-year guidance.
April 21, 2026: Newswire and media outlets (PR Newswire, AP, RTT/dpa-AFX) distributed the results.
April 21, 2026: Zacks consensus comparison published; results reported to have topped estimates.
April 21, 2026: Pre-market trading showed Quest shares rising following the guidance update.

Why This Matters to You

Quest Diagnostics' strong Q1 results could impact your wallet. If you own shares, you're likely seeing a boost in your investment. If you're considering investing, this might be a company to watch. Check your portfolio or speak with your financial advisor.

The Bottom Line

Quest is showing solid growth and beating estimates, which is good news for shareholders and potential investors. Their revised 2026 outlook could mean continued growth. Worth forwarding if you know someone thinking about investing.